(Q44996694)

English

Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial (English)

1 reference

Europe PubMed Central

8 December 2017

focal segmental glomerulosclerosis

1 reference

based on heuristic

inferred from title

author name string

Hong Ren

1

1 reference

Europe PubMed Central

8 December 2017

Pingyan Shen

2

1 reference

Europe PubMed Central

8 December 2017

Xiao Li

3

1 reference

Europe PubMed Central

8 December 2017

Xiaoxia Pan

4

1 reference

Europe PubMed Central

8 December 2017

Wen Zhang

5

1 reference

Europe PubMed Central

8 December 2017

Nan Chen

6

1 reference

Europe PubMed Central

8 December 2017

publication date

22 January 2013

1 reference

Europe PubMed Central

8 December 2017

American Journal of Nephrology

1 reference

Europe PubMed Central

8 December 2017

37

1 reference

Europe PubMed Central

8 December 2017

1

1 reference

Europe PubMed Central

8 December 2017

84-90

1 reference

Europe PubMed Central

8 December 2017

Trends in the epidemiology of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Other immunosuppressive agents for focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity.

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

2007 Young Investigator Award: TRP'ing into a new era for glomerular disease.

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

1 reference

https://api.crossref.org/works/10.1159%2F000346256

21 January 2018

Identifiers

10.1159/000346256

1 reference

Europe PubMed Central

8 December 2017

release_7euubeqk3bg7dn4iz4m2ad5ps4

1 reference

https://api.fatcat.wiki/v0/release/7euubeqk3bg7dn4iz4m2ad5ps4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44996694&oldid=2060757761"